Avanir Pharmaceutical a News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

27.09.19	Pharma Co. Charged With Paying Kichbacks, Targeting Elderly Patients (RTTNews)
30.04.18	Digital Trends welcomes Chris Carlson as COO, hires two new directors in April (PR Newswire)
19.04.17	Avanir Pharmaceuticals to Present Data on NUEDEXTA® and ONZETRA® Xsail® at American Academy of Neurology (AAN) 2017 Annual Meeting (PR Newswire)
13.04.17	"New York Times" Bestselling Author Tony Tjan Comments on United Airlines Incident (PR Newswire)
13.12.16	OriginClear Reports Leap In Large System Quotes Since Election (PR Newswire)
01.12.16	Mitsubishi Motors Reports November Sales (PR Newswire)
29.11.16	Avanir Pharmaceuticals Appoints Richard Malamut, MD, as Senior Vice President, Research & Development, and Chief Medical Officer (PR Newswire)
16.05.16	Avanir Announces U.S. Launch And Availability Of ONZETRA Xsail (RTTNews)
20.01.16	Avanir Pharma Names Rohan Palekar As President And CEO, Succeeding Katkin (RTTNews)
11.08.15	Avanir Prevails In NUEDEXTA Patent Appeal Maintaining Exclusivity Through 2026 (RTTNews)
30.06.15	Avanir: Positive Top-line Results From Stroke, TBI Cohorts Of PRISM II Study (RTTNews)
17.06.15	Avanir Reports Publication Of Positive Phase IIIb Results From AVP-825 Study (RTTNews)
16.02.15	Did You Make The Most Of These Secondary Offerings? (RTTNews)
30.12.14	Carbylan Therapeutics Appoints Three New Directors To Board - Quick Facts (RTTNews)
02.12.14	Avanir Pharma To Be Acquired By Japan's Otsuka In $3.5 Bln Cash Deal (RTTNews)
02.12.14	Avanir Pharma To Be Acquired By Otsuka For $3.5 Bln - Quick Facts (RTTNews)
27.11.14	FDA Says No To Avanir Pharma's Migraine Drug-Device AVP-825 (RTTNews)
07.11.14	Avanir Pharma: FDA Issues Prelim. Feedback On AVP-825 For Migraine (RTTNews)
13.10.14	Hudson Global Cuts Q3 Outlook (RTTNews)
08.10.14	Avanir To Present Data From Studies For Alzheimer's With Agitation, PBA Effect (RTTNews)
22.09.14	Avanir Pharma Announces $200 Mln Share Offering - Quick Facs (RTTNews)
16.09.14	AVNR Excites Investors, MRK To File Odanacatib NDA In 2015, Watch Out For ZSPH (RTTNews)
15.09.14	Avanir Reports Positive Results From Phase II Trial Of AVP-923 (RTTNews)
05.08.14	Avanir Pharma Reports Q3 Loss In Line (RTTNews)
10.06.14	Avanir Pharma Achieves Primary Endpoint In Phase IIIb COMPASS Trial- Quick Facts (RTTNews)
26.03.14	Avanir Pharma: FDA Accepts New Drug Application Of AVP-825 - Quick Facts (RTTNews)
31.01.14	ARAY On The Rise, AERI Catching Eyes, CORT Growing Big, SLXP Gets FDA Date (RTTNews)
30.01.14	Avanir Submits NDA For AVP-825 For Acute Treatment Of Migraine - Quick Facts (RTTNews)
11.12.13	AVNR's PRIME Flops, BG Medicine Tastes Sweet, CYTR Awaits Data, ENTA Shines (RTTNews)
23.10.13	EPZM, MDVN On Watch, MYGN In Legal Spat With BRLI, ONVO's 3D Story Gets Better (RTTNews)
22.10.13	Avanir Pharma Announces Enrollment Of First Patient In AVR-133 Study (RTTNews)
22.10.13	Avanir Pharmaceuticals Announces Enrollment of First Patient in Study of AVP-923 for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease (PR Newswire)
04.10.13	Avanir Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
01.10.13	Today's Technical View: Avanir Pharmaceuticals Inc., Warner Chilcott PLC, Actavis Inc., and Dynavax Technologies Corp. (PR Newswire)
20.09.13	Avanir Pharmaceuticals Announces Publication of AVP-825 Pharmacokinetic Data in Journal "Headache" (PR Newswire)
09.09.13	Sweet Tidings From BIOD, AVNR Hits New High, CEMP Honored, Watch Out For ONTX (RTTNews)
06.09.13	Avanir Pharma Settles NUEDEXTA Patent Litigation With Wockhardt (RTTNews)
06.09.13	Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Wockhardt (PR Newswire)
05.09.13	Avanir Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
04.09.13	RMTI Awaits CRUISE-2, AVNR On A High, ENTA Gets More Funds, Watch Out For ZLCS (RTTNews)
03.09.13	Avanir, Actavis Settle Patent Litigation - Quick Facts (RTTNews)
03.09.13	Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Actavis (PR Newswire)
02.09.13	Acquisitions, NDA Filings, Key Findings, Conferences and Product Launches - Research Report on Perrigo, Forest Labs, Avanir Pharmaceuticals, Cubist Pharmaceuticals, and Dr. Reddy's Laboratories (PR Newswire)
28.08.13	Today's Research: Avanir Pharmaceuticals Inc., Warner Chilcott plc, Actavis Inc., and Dynavax Technologies Corp. (PR Newswire)
15.08.13	SPRING Makes AMPE Jump, AVNR Buys Peace, FRX Delays NDA Submission (RTTNews)
14.08.13	B/E Aerospace To Buy Blue Dot Energy Services (RTTNews)
14.08.13	Avanir Reaches Settlement With Sandoz On Generic Versions Of Nuedexta Capsules (RTTNews)
14.08.13	Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Sandoz (PR Newswire)
13.08.13	GALT Vaults, BIOD, CCXI, ESPR Await Q3 Catalysts, Watch Out For OSIR (RTTNews)
12.08.13	Avanir Pharmaceuticals Inks Deal To Promote Merck's Januvia (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu Avanir Pharmaceuticals IncShs -A-

Aktien Top/Flop

Meistgelesene Nachrichten